> The EU negotiating team, according to people familiar with the talks, was intent on pushing down the price. In the middle of a pandemic that is literally costing trillions, this seems like the EU negotiators lost sight of the big picture.
I was under the assumption that the Oxford/AstraZeneca vaccine was being produced at cost under the agreement with Oxford University. I'm curious as to what cost savings they were after - possibly on distribution or in establishing the manufacturing bases?
However trying to get a $3 vaccine down to $2 is laughable for what is essentially the wealthiest trading block on the planet, even their poorest member could afford to cover the entire union.